CAS: 57227-08-4 - alpha-(Benzoylamino)-4-(benzoyloxy)-N,N-dipropylbenzenepropanamide
Fórmula:C29H32N2O4
InChI:InChI=1/C29H32N2O4/c1-3-19-31(20-4-2)28(33)26(30-27(32)23-11-7-5-8-12-23)21-22-15-17-25(18-16-22)35-29(34)24-13-9-6-10-14-24/h5-18,26H,3-4,19-21H2,1-2H3,(H,30,32)
- Sinónimos:
- alpha-(Benzoylamino)-4alpha-(Benzoylamino)-4-(benzoyloxy)-N,N-dipropylbenzenepropanamide
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Tiropramide Impurity B REF: 4Z-T-794CAS: 57227-08-4 | - - - | A consultar | Jue 02 Ene 25 |
 | N,O-Dibenzoyl-DL-tyrosyl-N’,N’-dipropylamide REF: TR-D422680CAS: 57227-08-4 | - - - | 309,00 €~1.962,00 € | Vie 10 Ene 25 |
 | α-(Benzoylamino)-4-(benzoyloxy)-N,N-dipropylbenzenepropanamide REF: 3D-FB148063CAS: 57227-08-4 | Min. 95% | A consultar | Mar 11 Feb 25 |
Tiropramide Impurity B
CAS:57227-08-4
Fórmula:
C29H32N2O4
Forma y color:
White To Off-White Solid
Peso molecular:
472.59
Ref: 4Z-T-794
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 2 de Enero de 2025
N,O-Dibenzoyl-DL-tyrosyl-N’,N’-dipropylamide
Producto controladoCAS:57227-08-4
Applications N,O-Dibenzoyl-DL-tyrosyl-N',N'-dipropylamide is a metabolite of the antispasmodic agent Tiropramide (T446900). Tiropramide impurity B. References …
Fórmula:
C29H32N2O4
Forma y color:
White To Light Red
Peso molecular:
472.58
Ref: TR-D422680
| 1g | 309,00 € | ||
| 10g | 1.962,00 € |
Entrega estimada en Estados Unidos, el Viernes 10 de Enero de 2025
α-(Benzoylamino)-4-(benzoyloxy)-N,N-dipropylbenzenepropanamide
CAS:57227-08-4
Please enquire for more information about alpha-(Benzoylamino)-4-(benzoyloxy)-N,N-dipropylbenzenepropanamide including the price, delivery time and more detailed …
Fórmula:
C29H32N2O4
Pureza:
Min. 95%
Peso molecular:
472.58 g/mol
Ref: 3D-FB148063
| 1g | 678,00 € | ||
| 2g | 1.033,00 € | ||
| 250mg | 338,00 € | ||
| 500mg | 457,00 € |
Entrega estimada en Estados Unidos, el Martes 11 de Febrero de 2025
